179 related articles for article (PubMed ID: 30480261)
1. Should the Treatment of Amyloidosis Be Personified? Molecular Mechanism of Amyloid Formation by Aβ Peptide and Its Fragments.
Galzitskaya OV; Surin AK; Glyakina AV; Rogachevsky VV; Selivanova OM
J Alzheimers Dis Rep; 2018 Oct; 2(1):181-199. PubMed ID: 30480261
[TBL] [Abstract][Full Text] [Related]
2. [Molecular mechanism of amyloid formation by Ab peptide: review of own works].
Selivanova OM; Rogachevsky VV; Syrin AK; Galzitskaya OV
Biomed Khim; 2018 Jan; 64(1):94-109. PubMed ID: 29460839
[TBL] [Abstract][Full Text] [Related]
3. Rosetta Stone for Amyloid Fibrils: The Key Role of Ring-Like Oligomers in Amyloidogenesis.
Galzitskaya OV; Selivanova OM
J Alzheimers Dis; 2017; 59(3):785-795. PubMed ID: 28671122
[TBL] [Abstract][Full Text] [Related]
4. The Mechanism Underlying Amyloid Polymorphism is Opened for Alzheimer's Disease Amyloid-β Peptide.
Selivanova OM; Surin AK; Marchenkov VV; Dzhus UF; Grigorashvili EI; Suvorina MY; Glyakina AV; Dovidchenko NV; Galzitskaya OV
J Alzheimers Dis; 2016 Sep; 54(2):821-30. PubMed ID: 27567850
[TBL] [Abstract][Full Text] [Related]
5. New Mechanism of Amyloid Fibril Formation.
Galzitskaya O
Curr Protein Pept Sci; 2019; 20(6):630-640. PubMed ID: 30686252
[TBL] [Abstract][Full Text] [Related]
6. One of the possible mechanisms of amyloid fibrils formation based on the sizes of primary and secondary folding nuclei of Aβ40 and Aβ42.
Dovidchenko NV; Glyakina AV; Selivanova OM; Grigorashvili EI; Suvorina MY; Dzhus UF; Mikhailina AO; Shiliaev NG; Marchenkov VV; Surin AK; Galzitskaya OV
J Struct Biol; 2016 Jun; 194(3):404-14. PubMed ID: 27016282
[TBL] [Abstract][Full Text] [Related]
7. Unique molecular signatures of Alzheimer's disease amyloid β peptide mutations and deletion during aggregate/oligomer/fibril formation.
Poduslo JF; Howell KG
J Neurosci Res; 2015 Mar; 93(3):410-23. PubMed ID: 25377128
[TBL] [Abstract][Full Text] [Related]
8. To Be Fibrils or To Be Nanofilms? Oligomers Are Building Blocks for Fibril and Nanofilm Formation of Fragments of Aβ Peptide.
Selivanova OM; Surin AK; Ryzhykau YL; Glyakina AV; Suvorina MY; Kuklin AI; Rogachevsky VV; Galzitskaya OV
Langmuir; 2018 Feb; 34(6):2332-2343. PubMed ID: 29338255
[TBL] [Abstract][Full Text] [Related]
9. Elucidating the Structures of Amyloid Oligomers with Macrocyclic β-Hairpin Peptides: Insights into Alzheimer's Disease and Other Amyloid Diseases.
Kreutzer AG; Nowick JS
Acc Chem Res; 2018 Mar; 51(3):706-718. PubMed ID: 29508987
[TBL] [Abstract][Full Text] [Related]
10. A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling.
Gu L; Tran J; Jiang L; Guo Z
J Struct Biol; 2016 Apr; 194(1):61-7. PubMed ID: 26827680
[TBL] [Abstract][Full Text] [Related]
11. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
Matsuzaki K
Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
[TBL] [Abstract][Full Text] [Related]
12. Comparison of neurotoxicity of different aggregated forms of Aβ40, Aβ42 and Aβ43 in cell cultures.
Fu L; Sun Y; Guo Y; Chen Y; Yu B; Zhang H; Wu J; Yu X; Kong W; Wu H
J Pept Sci; 2017 Mar; 23(3):245-251. PubMed ID: 28211253
[TBL] [Abstract][Full Text] [Related]
13. Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.
Nguyen P; Derreumaux P
Acc Chem Res; 2014 Feb; 47(2):603-11. PubMed ID: 24368046
[TBL] [Abstract][Full Text] [Related]
14. Studies of the Process of Amyloid Formation by Aβ Peptide.
Galzitskaya OV; Galushko EI; Selivanova OM
Biochemistry (Mosc); 2018 Jan; 83(Suppl 1):S62-S80. PubMed ID: 29544432
[TBL] [Abstract][Full Text] [Related]
15. Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage.
Ferrera D; Mazzaro N; Canale C; Gasparini L
Neurobiol Aging; 2014 Nov; 35(11):2444-2457. PubMed ID: 24973120
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation.
Feng Y; Wang XP; Yang SG; Wang YJ; Zhang X; Du XT; Sun XX; Zhao M; Huang L; Liu RT
Neurotoxicology; 2009 Nov; 30(6):986-95. PubMed ID: 19744518
[TBL] [Abstract][Full Text] [Related]
17. N-Terminus Binding Preference for Either Tanshinone or Analogue in Both Inhibition of Amyloid Aggregation and Disaggregation of Preformed Amyloid Fibrils-Toward Introducing a Kind of Novel Anti-Alzheimer Compounds.
Dong M; Zhao W; Hu D; Ai H; Kang B
ACS Chem Neurosci; 2017 Jul; 8(7):1577-1588. PubMed ID: 28406293
[TBL] [Abstract][Full Text] [Related]
18. Aβ42 fibril formation from predominantly oligomeric samples suggests a link between oligomer heterogeneity and fibril polymorphism.
Xue C; Tran J; Wang H; Park G; Hsu F; Guo Z
R Soc Open Sci; 2019 Jul; 6(7):190179. PubMed ID: 31417723
[TBL] [Abstract][Full Text] [Related]
19. Increased Secondary Nucleation Underlies Accelerated Aggregation of the Four-Residue N-Terminally Truncated Aβ42 Species Aβ5-42.
Weiffert T; Meisl G; Flagmeier P; De S; Dunning CJR; Frohm B; Zetterberg H; Blennow K; Portelius E; Klenerman D; Dobson CM; Knowles TPJ; Linse S
ACS Chem Neurosci; 2019 May; 10(5):2374-2384. PubMed ID: 30793584
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of Amyloid Gel Formation by Several Short Amyloidogenic Peptides.
Galzitskaya OV; Selivanova OM; Gorbunova EY; Mustaeva LG; Azev VN; Surin AK
Nanomaterials (Basel); 2021 Nov; 11(11):. PubMed ID: 34835893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
